Login to Your Account



Innocoll shares crash as Xaracoll draws FDA RTF letter

By Michael Fitzhugh
Staff Writer

Friday, December 30, 2016

An NDA for Xaracoll must be filed as a drug/device combination product, the FDA said, dashing company hopes for an August 2017 approval.

To continue reading subscribe now to Latest News

Learn More about Latest News

Already a subscriber? Sign In or Buy now to activate your subscription